Research Article

Evolutionary Analysis and Phylodynamics of Avian Influenza Virus H5N1 between 2015 and 2016 in Egypt

Osama Elshazly1, AbdelSatar Arafa1, Mohammed A. Rohaim2, Ismaeil M. Reda2 and Hussein A. Hussein2*

1National Laboratory for Veterinary Quality Control on Poultry Production, Animal Health Research Institute, 12618, Egypt; 2Virology Department, Faculty of Veterinary Medicine, Cairo University, 12211, Egypt.

Received | August 29, 2017; Accepted | October 12, 2017; Published | April 25, 2018

*Correspondence | Prof. Hussein Aly Hussein Ahmed, Virology Department, Faculty of Veterinary Medicine, Cairo University, Egypt; Email: [email protected]

DOI | http://dx.doi.org/10.17582/journal.hv/2018/5.2.17.25

Citation | Elshazly, O., Arafa, A., Rohaim, M.A., Reda, I.M. and Hussein, H.A. 2018. Evolutionary analysis and phylodynamics of avian influenza virus H5N1 between 2015 and 2016 in Egypt Hosts and Viruses, 5(2): 17-22.

Keywords: Zoonotic, Egypt, Selection pressures, Phylogeny, Evolution.

Introduction

A clade 2.2 avian influenza virus (AIV) was detected in wild birds in Egypt in 2005 and was later isolated from poultry in February 2006, causing severe economic losses to the Egyptian poultry industry (Saad et al., 2007). A clade-based classification system has been established considering the clustering pattern of the HA genes and a total of 10 distinct H5N1 clades (clades 0–9) is now well established (WHO/OIE/FAO H5N1 Evolution Working Group, 2009). These clades can be further classified into sub-clades due to the continuous evolution of these viruses.

In 2008, H5N1 viruses in Egypt were classified as subclade 2.2.1 and declared to be enzootic, causing severe economic losses to the commercial poultry sector as well as posing a threat to public health due to the zoonotic propensity of the virus (Abdelwhab and Hafez, 2011). By 2012, the WHO/OIE/FAO H5N1 Evolution Working Group recommended that the Egyptian clade 2.2.1 be split into two new subclades, 2.2.1.1; and 2.2.1.2, indicating further divergence of H5N1 viruses circulating in Egyptian poultry (WHO/OIE/FAO H5N1 Evolution Working Group, 2014). From 2007 to 2014, viruses of subclade 2.2.1.1 are being circulated in vaccinated poultry, including turkeys despite intensive vaccination using over 20 diverse H5 vaccines (Abdelwhab et al., 2016). Meanwhile, subclade 2.2.1.2 viruses were observed initially in backyard birds and humans, and recently in commercial birds. The 2.2.1.2 viruses caused severe socioeconomic losses in the poultry industry and posed a serious pandemic threat because of their affinity to human-type receptors (Arafa et al., 2015). Human infections with viruses of the newly emerged 2.2.1.2 subclade amounted to 136 cases with a case fatality rate of 34.8 % in 2015. Therefore, the H5N1 AI situation in Egypt is alarming (WHO, 2016).

The causes of the recent upsurge in poultry outbreaks due to 2.2.1.2 H5N1 infection in parallel of human cases in Egypt remained unclear. There is now ample evidence that the human cases were caused by the newly emerged phylotype 2.2.1.2, for which there was a large increase in the incidence of outbreaks in poultry holdings (Arafa et al., 2016). Thus, there is an urgent need to study and trace the genetic variations among H5N1 viruses circulating in Egypt. In this study, full length HA sequencing and phylogenetic analyses of six HPAI H5N1 viruses isolated during 2015–2016 through systematic surveillance in Egypt were conducted.

Material and Methods

Cloacal and oropharyngeal swabs were collected from five Egyptian governorates during routine AI surveillance between 2015 and 2016, from commercial and backyards sectors; 1187 samples from commercial sectors and 813 samples from backyard sectors during 2015, while in 2016, 2484 samples from commercial sectors and 718 samples from backyard sectors. Pooled swabs were placed in transport medium, consisting of phosphate-buffered saline containing glycerol, penicillin (2000 U/ml), gentamicin (250 mg/ml) and nystatin (500 U/ml). Collected swabs were sent to the National Laboratory for Veterinary Quality Control on Poultry Production, Animal Health Research Institute, Egypt for routine diagnosis and further virus characterization. Virus isolation from swab samples was done in 9-day old specific-pathogen-free (SPF) embryonated chicken eggs (ECE) according to OIE guidelines (OIE, 2013). Inoculated eggs were examined daily for 3 – 5 days. Eggs with dead embryos were kept at 4°C for 24 h. Allantoic fluid was collected and examined using the standard hemagglutination test and 1% chicken erythrocytes (OIE, 2013).

Sequence similarity to the HA gene of the viruses isolated in this study was probed by Basic Local Alignment Search Tool (BLAST) database available at the NCBI (Altschul et al., 1990). Sequences with the maximum BLAST scores and identity percentages were selected. Moreover, representative Egyptian viruses from subclades 2.2.1.2 and 2.2.1.1 were included in the analysis. All sequences were aligned using Multiple Alignment using Fast Fourier Transform (MAFFT) (Katoh et al., 2014) and further viewed and edited by BioEdit 7.1.7 (Hall, 1990). Amino acid sequences were deduced from gene sequences and identity matrices were calculated using BioEdit. Bayesian inference phylogenetic trees for HA gene segment were generated using MrBayes 3.2.6 (Ronquist et al., 2012) under best-fit models calculated by jModelTest (Santorum et al., 2014). Two parallel runs consisted of four chains of Markov Chain Monte Carlo (MCMC) iterations for 108 generations were selected for each nucleotide sequence. For the phylogenetic tree A/goose/Guangdong/1/1996 (H5N1) (Clade 0) was specified as the out-group. Graphic outputs were produced by FigTree (http://tree.bio.ed.ac.uk/software/figtree/) and Inkscape 0.91 (www.inkscape.org).

To determine the selection pressure for HA gene segment, 93 sequences of H5N1 viruses circulating in Egypt during 2006–2016 were analyzed by estimating the ratio of non-synonymous (dN) to synonymous (dS) substitutions (ω=dN/dS) across the lineages on a codon-by-codon basis. Selective pressure was defined as follows; ω =1 indicates neutral evolution, ω ˂1 indicates negative or purifying selective pressure and ω >1 indicates positive selection. The mean values of ω were calculated by the SLAC and FEL methods using the Datamonkey website (http://www.datamonkey.org) (Delport et al., 2010).

Results and Discussion

Although most of the countries earlier infected with HPAI H5N1 viruses have succeeded in eliminating their territories after the initial outbreaks, the virus persists in some South-East Asian countries, including China, Indonesia, Vietnam, and Bangladesh as well as Egypt (FAO, 2013). In spite of previous studies that described the temporal and spatial patterns of HPAI outbreaks that occurred in backyard and commercial poultry sectors in Egypt, there are still obstacles that hinder the improvement of control strategies. First, the mechanism of HPAI H5N1 virus spread and persistence and the role of human-animal interactions with human infections are only partially explored. Secondly, detailed HPAI epidemiological information and data integrity are lacking in the Egyptian poultry industry (Abdelwhab and Hafez, 2011; Arafa et al., 2016).

In the present study, five Egyptian governorates were chosen (Minya, Aswan, Daqahlya, Gharbia and Cairo) in which to study the epidemiological pattern of AI based upon; 1) their locations in Upper and Lower Egypt, 2) high density of rearing and 3) rate of human risk infection with AI. Based on previous reports, H5N1 outbreaks were detected in both Upper and Lower Egypt and affected 96.3% (26/27) of all governorates in Egypt, with higher prevalence in Lower Egypt (Sharkia, Qalyobia, Menufia, Daqahlya and Gharbia) than Upper Egypt (Giza, Fayoum and Minya) (El-Masry et al., 2015). In this study, 2000 and 3202 samples were collected during routine surveillance for AI epidemiology in 2015 and 2016, respectively. During 2015, 1187 samples were collected from commercial sectors, and only 10 cases were positive, while in the same year backyard sectors showed more positive cases with 69 positive cases out of the 813 collected samples. In 2016, 3202 samples were collected (2484 from commercial sectors with only 4 positive cases, and 718 cases from backyard sectors with 31 positive case) (Figure 1). Testing of the collected samples by real time RT-qPCR revealed positives for type A avian influenza virus with Ct value ranged between 20 and 24. Positive samples were inoculated into ECEs and tested by HA assays, which ranged between 6-9 log2 from which six representative isolates were chosen for further genetic analysis (Table 1).

To date, Egypt is among the countries with the highest number of human fatalities due to zoonotic H5N1 infections directly related to intense and persistent infection in poultry flocks. Previous studies have suggested that recurrent human infections may be occurring primarily through droplet transmission arising from close contact with infected poultry (Murray and Morse, 2011). In Egypt, the highest incidence remains in the Nile Delta region, where high densities of poultry populations and activities have been established alongside dense human populations. The unorganized marketing networks and poultry’s spatial distributions within the human household are possible risk factors for human infections (WHO, 2015).

Influenza H5N1 viruses have five antigenic sites within the HA viral surface glycoprotein, which is a major determinant of influenza virus host range; mutations in these HA sites play an important role in the evolution of H5N1 (Shih et al., 2007). Analysis of antigenic site B (D154, A156 and A184) showed that

Table 1: Data of the reported isolates.

*Province/Government where specimens were collected from.

Table 2: Amino acid substitutions at different sites of HA protein.

*Amino acid positions according to H5 numbering (Duvvuri et al., 2009).

most of the subclade 2.2.1.2 viruses had mutations D154N. Additionally, seven new sites were described recently as antibody-binding sites (N94, S120, R162, E227, N252, T263 and I282) (Cai et al., 2012). Site E227 was conserved in all Egyptian viruses, whereas subclade 2.2.1.2 viruses possessed mutations S120D, R162K, Y252N and G282S in comparison to the original clade 2.2.1. Moreover, there is another mutation is located in the stalk domain at the oligomerization interface of the HA protein at residue K373R, which is characteristic for the emerging of new clades (Duvvuri et al., 2009) and noted in our isolates in this study. Antigenic drift, the accumulation of point mutations in the viral genome, creates virus variants that escape immunity to previous influenza strains, necessitating continuous alterations to the vaccine strains (Hoelscher et al., 2008). More point mutations were noted at sites along the HA protein, which are provided in Table 2.

After the first introduction of the H5N1 HPAI virus in Egypt in February 2006, a huge number of disease outbreaks was reported in commercial farms because of the newly introduced H5N1 virus, clade 2.2.1 (Aly et al., 2008). The infection was characterized by severe destruction of poultry and widespread occurrence into the country. From December 2007 to May 2008, the emergence of a new variant escape mutant subclade 2.2.1.1 was documented from, primarily, vaccinated flocks. After that, from November 2010 till now; an endemic emerging new subclade 2.2.1.2 was characterized by severe epidemics mainly in backyard poultry as well as commercial sectors and associated with frequent human infections (Arafa et al., 2015). The new subclade 2.2.1.2 showed a high evolution rate over a period of 6 years (6.7 × 10−3/site/year). Likewise, differences in the nucleotide composition of the coding sequence of HA gene was up to 1.3%, which includes up to fourteen specific fixed nucleotide substitutions distinguishing these viruses from earlier Egyptian isolates before 2014.

Phylogenetic analysis of these HA sequences was carried out to further identify the genetic spectrum and evolution of H5N1 AIVs which revealed persistent virus evolution and predominance of the endemic subclade 2.2.1.2 cluster in Egypt with establishment of a new cluster for the recent poultry isolates starting from 2015 and human isolates (Figure 3). Subclade 2.2.1.2 viruses has specific signatures (aa D43N, S120D, Δ129S, I151T, R162K, G272S, R325K) which enable efficient replication in human cells (Watanabe et al.  2015; Schmier et al., 2015) and several point mutations in the immunogenic epitopes mostly in the HA1 domain were observed which enabled the latter viruses to escape from the humoral immune response induced by H5 vaccines leading to vaccination failure in chickens (Duvvuri et al., 2009; Cattoli et al., 2011). Recent studies demonstrated that five mutations in the H5N1 viruses may be required to enable transmission between ferrets via respiratory droplets; these four mutations in HA (Q222L, G224S, T156A and H103Y) and one in the PB2 protein (E627K) (Herfst et al., 2012).

• • Abdelwhab, E., Hafez, H. 2011. An overview of the epidemic of highly pathogenic H5N1 avian influenza virus in Egypt: epidemiology and control challenges. Epidemiol. Infect. 139:647-57.
• • Abdelwhab, E,M,, Veits, J., Tauscher, K., Ziller, M., Grund, C., Hassan, M.K., Shaheen, M., Harder, T.C., Teifke, J., Stech, J., Mettenleiter, T.C. 2016. Progressive glycosylation of the haemagglutinin of avian influenza H5N1 modulates virus replication, virulence and chicken to chicken transmission without significant impact on antigenic drift. J Gen Virol. 97(12):3193-3204
• • Altschul, S.F., Gish, W., Miller, W., Myers, E.W., Lipman, D.J. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
• • Aly, M. M., Arafa, A., Hassan, M.K. 2008. Epidemiological findings of outbreaks of disease caused by highly pathogenic H5N1 avian influenza virus in poultry in Egypt during 2006. Avian Dis. 52:269–277.
• • Arafa, A., El-Masry, I., Kholosy, S., Hassan, M.K., Dauphin, G., Lubroth, J., Makonnen, Y.J. 2016. Phylodynamics of avian influenza clade 2.2.1 H5N1 viruses in Egypt. Virol. J. 13:49.
• • Arafa, A., Naguib, M., Luttermann, C., Selim, A., Kilany, W., Hagag, N., Samy, A., Abdelhalim, A., Hassan, M., Abdelwhab, E. 2015. Emergence of a novel cluster of influenza A (H5N1) virus clade 2.2.1.2 with putative human health impact in Egypt, 2014/15. Euro Surveill. 20: 2-8.
• • Cai, Z., Ducatez, M.F., Yang, J., Zhang, T., Long, L.P., Boon, A.C., Webby, R.J., Wan, X. F. 2012. Identifying antigenicity-associated sites in highly pathogenic H5N1 influenza virus hemagglutinin by using sparse learning. J. Mol. Biol. 422, 145–155.
• • Cattoli, G., Milani, A., Temperton, N., Zecchin, B., Buratin, A., Molesti, E., Aly, M.M., Arafa, A., Capua, I. 2011. Antigenic drift in H5N1 avian influenza virus in poultry is driven by mutations in major antigenic sites of the hemagglutinin molecule analogous to those for human influenza virus. J. Virol. 85: 8718–24.
• • Delport, W., Poon, A. F., Frost, S. D., Kosakovsky Pond, S. L. 2010. Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology. Bioinformatics. 26, 2455 2457.
• • Drummond, A.J., Ho, S.Y., Phillips, M.J., Rambaut, A. 2006. Relaxed phylogenetics and dating with confidence. PLoS Biol. 4:699–710.
• • Drummond, A.J. and Rambaut. A. 2007. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol. 7:214.
• • Duvvuri, V.R., Duvvuri, B., Cuff, W.R., Wu, G.E., Wu, J. 2009. Role of positive selection pressure on the evolution of H5N1 hemagglutinin. Genomics Proteomics Bioinformatics. 7: 47–56. 40.
• • FAO, 2011. Approaches to controlling, preventing and eliminating H5N1 highly pathogenic avian influenza in endemic countries. Food and Agriculture Organization, Rome, Italy. Available from: http://www.fao.org/docrep/014/i2150e/i2150e00.htm
• • FAO, 2013. Mapping influenza A (H5N1) virus transmission pathways and critical control points in Egypt. Food and Agriculture Organization, Rome, Italy. Available from: http://www.fao.org/docrep/017/i3272e/i3272e.pdf
• • Grund, C, Abdelwhab, el-S.M., A, Arafa, A.S., Ziller, M., Hassan, M.K., Aly, M.M., Hafez, H.M., Harder, T.C., Beer, M. 2011. Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate. Vaccine. 29:5567–73.
• • Hall, T.A. 1999. BioEdit: A User-Friendly Biological Sequence Alignment Editor and Analysis Program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41, 95-98.
• • Herfst, S., Schrauwen, E.J., Linster, M., Chutinimitkul, S., de Wit, E., Munster, V.J., Sorrell, E.M., Bestebroer, T.M., Burke, D.F., Smith, D.J., Rimmelzwaan, G.F., Osterhaus, A.D., Fouchier, R.A. 2012. Airborne transmission of influenza A/H5N1 virus between ferrets. Science. 336, 1534–1541.
• • Hoelscher, M.A., Singh, N., Garg, S., Jayashankar, L., Veguilla, V., Pandey, A., Matsuoka, Y., Katz, J.M., Donis, R., Mittal, S.K., Sambhara, S. 2008. A broadly-protective vaccine against globallydispersed clade 1 and clade 2 H5N1 viruses. J. Inf. Dis. 197, 1185–1188.
• • Hoffmann, B., Harder, T., Starick, E., Depner, K., Werner, O., Beer, M. Rapid and highly sensitive pathotyping of avian influenza A H5N1 virus by using real-time reverse transcription-PCR. J. Clin. Microbiol. 45: 600-3 
• • Hoffmann, E., Stech, J., Guan, Y., Webster, R.G., Perez, D.R. 2001. Universal primer set for the full-length amplification of all influenza viruses. Arch. Virol. 146:2275–2289.
• • Imai, M., Watanabe, T., Hatta, M., Das, S. C., Ozawa, M., Shinya, K., Zhong, G., Hanson, A., Katsura, H., Watanabe, S., Li, C., Kawakami, E., Yamada, S., Kiso, M., Suzuki, Y., Maher, E.A., Neumann, G., Kawaoka, Y. 2012. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486, 420–428.
• • Katoh, K., Misawa, K., Kuma, K., Miyata, T. 2002. MAFFT: A novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res. 15; 3 0(14):3059-66.
• • Kreibich, A., Stech, J., Mettenleiter, T.C., Stech, O., 2009. Simultaneous one-tube full length amplification of the NA, NP, M, and NS genes of influenza A viruses for reverse genetics. J. Virol. Methods 159, 308–310.
• • Minin VN, Bloomquist EW, Suchard MA. 2008. Smooth skyride through a rough skyline: Bayesian coalescent-based inference of population dynamics. Mol Biol Evol. 25:1459–71.
• • Murray EJ, Morse SS, 2011. Seasonal oscillation of human infection with influenza A/H5N1 in Egypt and Indonesia. PloS One 6:e24042.
• • OIE, 2013. OIE Tool for the Evaluation of the Performance of Veterinary Services (OIE PVS Tool), 6th Ed. OIE, Paris, 56 pp. Available at: www.oie.int/fileadmin/Home/eng/Support_to_OIE_ Members/pdf/PVS_A_Tool_Final_Edition_2013.pdf
• • Peyre M, Samaha H, Makonnen YJ, Saad A, Abd-Elnabi A, Galal S, Ettel T, Dauphin G, Lubroth J, Roger F, Domenech J, 2009. Avian influenza vaccination in Egypt: limitations of the current strategy. J. Mol. Genet. Med. 3(2):198-204.
• • Rambaut A, Drummond AJ. 2007. Tracer v1.4: MCMC trace analyses tool. http://beast.bio.ed.ac.uk/Tracer. Accessed 20 June 2008.
• • Ronquist F. et al. (2012) ‘MrBayes 3.2: efficient Bayesian phylogenetic inference and model choice across a large model space’, Systematic Biology, 61/3: 539–42.
• • Saad, M. D., Ahmed, L. S., Gamal-Eldein, M. A., Fouda, M. K., Khalil, F., Yingst, S. L., Parker, M. A. & Montevillel, M. R. 2007. Possible avian influenza (H5N1) from migratory bird, Egypt. Emerg. Infect. Dis. 13(7): 1120-1.
• • Santorum J.M., Darriba D., Taboada G.L., Posada D. (2014) jmodeltest.org: selection of nucleotide substitution models on the cloud. Bioinformatics, 30, 1310–1311.
• • Schmier S, Mostafa A, Haarmann T, Bannert N, Ziebuhr J, Veljkovic V, Dietrich U, Pleschka S. 2015. In silico prediction and experimental confirmation of HA residues conferring enhanced human receptor specificity of H5N1 influenza a viruses. Sci Rep. 5: 11434.
• • Shih, A.C., Hsiao, T.C., Ho, M.S., Li, W.H. 2007. Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. Proc. Nat. Acad. Sci. USA. 104, 6283–6288.
• • Watanabe, Y., Arai, Y., Daidoji, T., Kawashita, N., Ibrahim, M.S., El-Gendy, Eel D., Hiramatsu. H., Kubota-Koketsu, R., Takagi, T., Murata, T.,  Takahashi, K., Okuno, Y., Nakaya, T., Suzuki Y., Ikuta, K. 2015. Characterization of H5N1 influenza virus variants with hemagglutinin mutations isolated from patients. MBio. 2015; 6 (2).
• • Watanabe, Y., Ibrahim, M. S., Ellakany, H. F., Kawashita, N., Mizuike, R., Hiramatsu, H., Sriwilaijaroen, N., Takagi, T., Suzuki, Y., Ikuta, K. 2011. Acquisition of human-type receptor binding specificity by new H5N1 influenza virus sublineages during their emergence in birds in Egypt. PLoS Pathog 7, e1002068.
• • WHO, 2016. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2016. World Health Organization, Geneva, Switzerland. Available from: http://www.who.int/influenza/human_animal_interface/2016_07_19_tableH5N1.pdf?ua=1
• • WHO-EMRO, 2015. Egypt: upsurge in H5N1 human and poultry cases but no change in transmission pattern of infection, 2015. World Health Organization Regional Office for Eastern Mediterranean, Cairo, Egypt. Available from: http://www.emro.who.int/egy/egypt-news/upsurge-h5n1-human-poultry-cases-may-2015.html
• • WHO-OIE-FAO H5 Evolution Working Group, 2014. Revised and updated nomenclature for highly pathogenic avian influenza A (H5N1) viruses. Influenza and other respiratory viruses 8, 384-388.
• • WHO-OIE-FAO, H5 Evolution Working Group, 2009. Continuing progress towards a unified nomenclature for the highly pathogenic H5N1 avian influenza viruses: divergence of clade 2.2 viruses. Influenza and other respiratory viruses 3, 59-62.